Market Research Blog

The Virtualized Evolved Packet Core (vEPC) Market revenues were estimated at US$ 4.8 Bn in 2021 and is anticipated to grow at a CAGR of 15.9% from 2022-2032, according to a recently published Future Market Insights report. The market is expected to reach a valuation of US$ 5.9 Bn in 2022 and US$ 26 Bn by the end of 2032.

The key component for Virtualized Evolved Packet Core (vEPC) Market include Services where the Demand growth of Virtualized Evolved Packet Core (vEPC) Market through Services was recorded at 23.4% during 2015 – 2021, while it is expected to grow at a CAGR of 15.6% during 2022 –2023.

The key factors which are propelling the Virtualized Evolved Packet Core demand include chances for MNOs to benefit from the expansion of the IoT sector. It is anticipated that mobile network operators would commercially use virtual EPC in their live networks to serve a variety of use cases. In the heterogeneous IoT world, the ability for MNOs to cost-effectively modify their networks for specific clients, sectors, and applications is crucial.

Request a Sample of this Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-15667

Additionally, it enables ISPs and businesses to connect mobile and IoT devices, data centers, and public or private clouds by supporting low-latency use cases at the network edge. By connecting all different kinds of devices, systems, and services, the Internet of Things and the ongoing development of Machine-to-Machine (M2M) communication networks have been revolutionizing several industries. IoT is one of the numerous use cases that 5G would allow and enable communication between a significant number of connected devices and sensors, with the help of network segmentation.

According to their application needs, high-performance, low-latency applications such as mobile video surveillance and low-power, low-latency, long-range IoT apps can be separated. The shift from LTE to 5G is expected to quicken in order to fulfill the demands for creating IoT applications, which are characterized as massive machine-type communication and mission-critical applications.

Competitive Landscape

Players in the market are constantly developing improved analytical solutions as well as extending their product offerings. The companies in Virtualized Evolved Packet Core are focused on their alliances, technology collaborations, and product launch strategies. The Tier 2 Players in the market are targeting to increase their Virtualized Evolved Packet Core share.

Some of the recent developments in the Virtualized Evolved Packet Core Market are:

• In January 2019, Mavenir is now vying for many bids and requests for information (RFIs) for mobile networks in the APAC area. Mavenir has started to offer a virtual radio access network alternative to the global mobile network supply oligopoly.
• In May 2019, Vodafone Idea Limited that it will employ Ericsson cloud packet core to enhance network performance. VIL will benefit from Ericsson’s key network features and applications, such as its Service-Aware Policy Controller (vSAPC), Virtualization Infrastructure (NFVI), and Virtual Evolved Packet Gateway (vEPG) solutions, which enable seamless business continuity and speedy rollout of new services.

Ask An Analyst @
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15667

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Virtualized Evolved Packet Core (vEPC) Market, presenting historical market data (2015-2021) and forecast statistics for the period of 2022-2032.

The study reveals extensive growth in Virtualized Evolved Packet Core (vEPC) Market in terms of Components (Solutions and Services) of Network Type, (5G Network and 4G Network) of Deployment Mode (Cloud and On-Premise) of End-User (Telecom Operators and Enterprises) of Application (LTE, VoLTE, and VoWiFi, IoT and M2M and Broadband Wireless Access) of across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Virtualized Evolved Packet Core Segmentation

By Components:

• Solutions
• Services

By Network Type:

• 5G Network
• 4G Network

By Deployment Mode:

• Cloud
• On-Premises

By End User:

• Telecom Operators
• Enterprises

By Application:

• LTE, VoLTE, and VoWiFi
• IoT and M2M
• Broadband Wireless Access

Request for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-15667

By Region:

• North America
• Latin America
• Europe
• APAC
• MEA

Check Related Links –    

https://lockabee.com/read-blog/32732

https://community.tradetheday.com/post/geofencing-market-2022—2032-global-analysis-size-share-incredible-growth—634d0981a236147a5bc4055e

https://bresdel.com/blogs/255572/Geofencing-Market-2022-Scope-of-Current-and-Future-Industry-2032

https://homment.com/7mm0kAFOFBhNZ044pcUz

https://inobee.com/read-blog/116832

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The global produced water treatment systems market is set to register a CAGR of 5.8% between 2022 and 2029 in comparison to 2.8% CAGR registered from 2014 to 2021. Rising water scarcity concerns, increased oil and gas activity, and stringent government regulations on produced water discharge are some of the factors driving the global produced water treatment systems market.

The largest volume of wastewater generated during oil and gas recovery operations is produced water. It has a high concentration of both soluble and insoluble particles, such as salt and oil. Hydrocarbons and other suspended particles in produced water are commonly removed using produced water treatment systems.

Through absorption and polishing, tertiary treatment technologies separate produced water from oil. To treat produced water, these technologies combine various technologies. According to FMI, ProSep, Inc. is the industry leader in tertiary treatment technology.

Download Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-86

FMI investigated the manufactured water treatment system market in North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

During the forecast period, North America is expected to gain 590 BPS in market share. Despite the fact that all three technologies are widely used in North America, tertiary technology was the largest in terms of market revenue in 2014, accounting for US$ 574 Mn, according to FMI’s analysis. During the forecast period, FMI expects the tertiary technology segment to grow at a double-digit CAGR.

Tertiary technology is more effective than both primary and secondary technology, owing to which it is being widely adopted by end-use industries. The tertiary technology segment of North America is expected to gain a whopping 1310 BPS during the forecast period.

FMI has divided the global produced water treatment systems market into three competitive landscapes: treatment systems, mobile systems and rental services, and commissioning and consulting services. Primary treatment technologies use fundamental techniques such as settling, media filtration, floatation, and biological aerated filtering to separate solids from water. According to FMI research, Alderley plc is one of the dominant players in primary treatment technologies.

Use Promo Code ->> “FMITODAY” to Get Flat 20% Discount

The onshore crude oil industry in North America represented 49.14 Bn barrels or nearly 80% of produced water in 2012. FMI expects this to reach 116.29 Bn barrels by the end of 2020.

The Asia Pacific is the second-largest market for produced water treatment systems after North America. The Asia Pacific produced water treatment systems market was worth US$ 960 Mn in 2014; FMI expects it to expand at a CAGR of over 2.8% during the forecast period 2014-2021.

Produced water is the largest volume of wastewater generated during oil and gas recovery operations. It contains high content of soluble and insoluble particles such as salt and oil. Produced water treatment systems are being extensively used for removing hydrocarbons and other suspended particles from this produced water.

Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-86

Produced Water Treatment Systems Market By Category

Capacity (thsnd bl/day):

• Less than 100
• 100 to 500
• Above 500

Technology:

• Primary
• Secondary
• Tertiary

Application:

• On Shore
• Off Shore

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia Pacific
• Middle East and Africa

Read More:

https://medium.com/@princepawar085/gaskets-and-seals-market-is-anticipated-to-hold-a-market-value-of-usd-102-bn-by-2026-1dd96383ef08

http://community.getvideostream.com/topic/89333/gaskets-and-seals-market-2022-increasing-demand-for-efficient-management-practices-report

https://waoop.com/read-blog/25058

https://princepawar0.blogspot.com/2022/10/gaskets-and-seals-market-share-global.html

https://liberiansocialnews.com/post/13441_global-gaskets-and-seals-market-2022-growth-covid-impact-trends-analysis-report.html

Global veterinary imaging market revenues will reach US$ 3.37 Bn by 2030, according to a study by Future Market Insights (FMI). The research study analyzes veterinary imaging market growth through 2030, in over 20+ countries. The study also offers incisive insights on key strategies of some of the leading players in the market.

According to the study, veterinary diagnostics market is witnessing investments, as pet humanization trend gains traction. Growing focus and government mandates on maintaining animal health is also likely to provide a boost to market growth.

The growth of the animal and pet care category as a whole will also spur growth. According to estimates from NAPHIA, the spending on pet food, pet insurance, and pet therapeutics have witnessed an increase in the recent past. The pet food category has in fact grown despite the Covid-19 crisis.

The broader gains in this market are likely to rub off on veterinary imaging market as well during the assessment period.

List of Key Players Covered in Veterinary Imaging market are:

• Esaote
• IDEXX Laboratories, Inc.
• IMV Technologies group
• Carestream Health
• Hallmarq Veterinary Imaging Ltd.
• MinXray, Inc.
• Universal Medical Systems, Inc.
• Agfa- Gevaert N.V.
• Mindray Medical International Ltd.
• GE Healthcare
• Siemens AG

The key market players are emphasizing on creating awareness about veterinary imaging devices to enter the untapped markets. For instance – in Oct 2018, GE Healthcare announced having inked a strategic agreement with SonoSim for encouraging training regarding ultrasound services.

“Technological advancements along with inorganic expansion are creating new strides for the veterinary imaging market. These trends are bound to catapult the veterinary imaging market to growth between 2022 and 2030”- says the FMI analyst.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12368

Key Takeaways

• Animal healthcare being a costly affair, people are shifting their gears to pet insurance
• The veterinary imaging market is driven by an ever-increasing number of veterinarians adopting imaging devices with reagents associated with them, which include PET, MRI, X-Ray radiology devices, and CT scanners
• Multi-slice CT scan systems expected to drive the market in the forecast period
• Asia-Pacific is slowly picking up with people turning the tide in favour of pet care
• Adoption of magnetic resonance imaging (MRI) systems continue to grow at a steady pace

Key Segments:

Veterinary Imaging Market by Product Type:

• Veterinary Imaging Equipment
  • Radiography (X-ray) Systems
    • Computed Radiography
    • Film-based Radiography
  • Ultrasound Imaging Systems
    • 2D US Imaging
    • 3D US Imaging
  • Magnetic Resonance Imaging Systems
  • Computed Tomography Systems
    • Single-slice CT
    • Multi-slice CT
  • Video Endoscopy Imaging Systems
  • Others
• Veterinary Imaging Software
• Veterinary Imaging Reagents
  • Ultrasound Contrast Reagents
  • MRI Contrast Reagents
  • X-Ray/CT Contrast Reagents
  • Nuclear Imaging Reagents

Veterinary Imaging Market by Animal Type:

• Small Animals
• Large Animals

Veterinary Imaging Market by Application:

• Cardiology
• Orthopedics
• Neurology
• Oncology
• Others

Veterinary Imaging Market by End User:

• Veterinary Clinics
• Veterinary Hospitals
• Veterinary Institutes and Research Centers

Veterinary Imaging Market by Region:

• North America Veterinary Imaging Market
• Latin America Veterinary Imaging Market
• Europe Veterinary Imaging Market
• East Asia Veterinary Imaging Market
• South Asia & Pacific Veterinary Imaging Market
• Middle East & Africa (MEA) Veterinary Imaging Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12368

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion & Exclusion/ Scope of the Report

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis

4.2. Regulatory Scenario

4.3. Key Promotional Strategies by the Manufacturers

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-12368

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global ankylosing spondylitis treatment market will continue to witness steady growth, driven by a slew of myriad, yet interconnected factors. A new report by ESOMAR-certified market research firm, Future Market Insights, offers incisive insights on key factors that will influence growth through 2030.

According to FMI’s report, the options for treatment include disease-modifying anti-rheumatic drugs (methotrexate), nonsteroidal anti-inflammatory drugs (naproxen, ibuprofen, celecoxib, meloxicam, and diclofenac), biologics (certolizumab pegol, secukinumab, infliximab), and biosimilars.

Key Takeaways from Ankylosing Spondylitis Treatment Market Study

• Nonsteroidal anti-inflammatory drugs lead the market as they are looked upon as the first line of treatment for ankylosing spondylitis
• Oral route of administration holds the largest market share due to simplicity of consumption.
• By age group, “adults” contribute to majority of revenue generation as ankylosing spondylitis usually gets initiated in adulthood.
• North America, led by the US, holds the highest market share due to well-established healthcare infrastructure, high incidences of ankylosing spondylitis, and innovations in pharmaceutical industry.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12345

Ankylosing Spondylitis Treatment Market Landscape

The major players in the ankylosing spondylitis market include Wyeth, Mitsubishi Tanabe, Schering-Plough, Takeda, Novartis AG, Amgen, Centocor, Abbott, Eisai, and Pfizer.

As per the Oxford University Press, around 1% of the US population, 1.3-1.56 Mn European population, and 4.63-4.98 Mn population in the Asia Pacific are affected by ankylosing spondylitis. Also, the market is witnessing massive investment on the part of research to table new formulations.

Inorganic growth parameters are also contributing a great deal to the growth of ankylosing spondylitis treatment market. For instance – Novartis AG, in Jan 2019, entered into a collaboration with TrialSpark with an objective of increasing patients’ access to the clinical trials. The enrollment timeline is expected to shorten, thereby speeding up development of novel therapies.

In Oct 2019, the European Commission approved Cosentyx to treat non-radiographic axial spondyloarthritis. The next step includes submission of label update application to US FDA and post approval, the market is expected to grow substantially.

“Agreement” is the other strategy used. For instance – Izana Bioscience, in Dec 2017, entered into a global license agreement with Takeda Pharmaceutical Company for manufacturing, commercializing, and developing Namilumab to treat ankylosing spondylitis.

Also, Zydus Cadila, in Nov 2017, launched Adalimumab’s biosimilar in India. It has been used to treat ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis.

Initiatives like these have been giving impetus to the ankylosing spondylitis market and the status quo is likely to remain the same in the forecast period.

Want More Insights?

The global ankylosing spondylitis treatment market is elaborated on the basis of drug class (Nonsteroidal Anti-inflammatory Drugs, Anti-Inflammatory Drugs, Immunosuppressive Drugs, TNF Blockers, JAK Inhibitors, Steroids, Biologics, and Others), route of administration (parenteral, oral), application (Adults, juvenile), and geography (North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA).

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-12345

Key Segment

Drug Class

• Nonsteroidal Anti-inflammatory Drugs
• Anti-Inflammatory Drugs
• Immunosuppressive Drugs
• TNF Blockers
• JAK Inhibitors
• Steroids
• Biologics
• Others

Route of Administration

• Parenteral
• Oral

Application

• Adults
• Juveniles

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12345

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The orthotic devices, casts and splints market will witness a CAGR of 6.2% between 2022 and 2024, according to a latest report by ESOMAR-certified market research firm Future Market Insights.

According to the study, the orthotic devices, casts, and splints market growth has dipped as a result of prioritization of COVID-19 care. Decrease in hospital visits has also led to a decrease in demand.

The authors of the study are confident of a recovery in 2021, however, demand is not likely to be as strong as pre-COVID levels. To sustain growth in a sluggish landscape, manufacturers will need to bank of innovative offerings, according to the study. The report is bullish about the use of 3D technology in the orthotic devices, casts, and splints market.

Key Takeaways of Orthotic Devices, Casts and Splints Market Study

• North America and Europe collectively hold over 60% of the market share
• Innovations to be a key growth driver in the developed countries, with 3D printing to catalyse the process
• Increase in osteoporosis and osteoarthritis to bolster the market in the forecast period

Ankle-Foot Orthosis to witness a Surge in Demand

AFO (ankle-foot orthosis) could be effectively used for supporting weak limbs or normalizing a limb with contracted muscles. Also, musculoskeletal and neurologic disorders cause the foot to drop.

AFOs could be used to control this foot drop as well. As such, AFOs could be used to address deformity as well as functional recovery.

North America, Europe, and Oceania have been witnessing an increase in demand for AFO due to increase in sports injuries. This trend is expected to continue in the forecast period as well.

“Launch of innovative and customized products in western countries coupled with eastern countries shifting towards lightweight fiberglass products to drive the orthotic devices, casts and splints market” – says the FMI analyst.

Future Belongs to 3D Technology

3D printed casts, with their open-lattice plastic design, are available in customized form. They are waterproof and help bones in healing faster.

These casts have upsurged the demand for personalized 3D printed medical devices. 3D printed orthoses are effective in treating children with cerebral palsy as well.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12059

Want more insights?

Orthotic devices, casts and splints market, a new study from Future Market Insights, opines on the orthotic devices, casts and splints from 2015 – 2019 and presents demand projections from 2020 – 2030 on the basis of product (casting supplies and equipment (plaster casts, casting tapes, cast cutters, casting tools and accessories), splinting supplies and accessories (fiberglass splints, plaster splints, other splints, splinting tools and accessories) and orthotics (functional orthotics and accommodative orthotics)), and distribution channel (Institutional sales (hospitals, orthopaedic clinics and nursing facilities) and retail sales (online sales, retail pharmacies and drug stores)) across seven prominent regions.

Market segmentation

Orthotic Devices, Casts, and Splints Market by Product Type:

• Casting Supplies & Equipment
  • Plaster Casts
  • Casting Tapes
  • Cast Cutters
  • Casting Tools and Accessories
• Splinting Supplies & Equipment
  • Fiberglass Splints
  • Plaster Splints
  • Other Splints
  • Splinting Tools and Accessories
• Orthotics
  • Functional Orthotics
  • Accommodative Orthotics

Orthotic Devices, Casts, and Splints Market by Distribution Channel:

• Institutional Sales
  • Hospitals
  • Orthopedic Clinics
  • Nursing Facilities
• Retail Sales
  • Online Sales
  • Retail Pharmacies
  • Drug Stores

Orthotic Devices, Casts, and Splints Market by Region:

• North America Orthotic Devices, Casts, and Splints Market
• Latin America Orthotic Devices, Casts, and Splints Market
• Europe Orthotic Devices, Casts, and Splints Market
• East Asia Orthotic Devices, Casts, and Splints Market
• South Asia & Pacific Orthotic Devices, Casts, and Splints Market
• Middle East & Africa (MEA) Orthotic Devices, Casts, and Splints Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12059

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Key Trends & Market Dynamics

1.3. Industry Evolution

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends
4. Key Success Factors

4.1. Product Adoption / Usage Analysis

4.2. Key Regulations

4.3. Orthotic Devices for Injury Prevention

5. COVID19 Crisis Analysis

5.1. Current COVID19 Statistics

5.2. Current GDP Projection and Probable Impact

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-12059

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market reached US$ 3.57 Bn in 2022 (up by 4.7% over 2021). Outbreak of Covid-19 in the short-term, backed by “innovation” in the long run, is expected to drive the market.

Sepsis, toxic shock syndrome, bacteremia, osteomyelitis, endocarditis, meningitis, pneumonia are amongst the life-threatening diseases caused by Staphylococcus Aureus bacteria. These diseases are cured by antibiotics.

Some form of staphylococcus aureus that has developed resistance to a broad range of antibiotics fall in the category of “Methicillin-Resistant Staphylococcus Aureus (MRSA)”. This resistance is one of the key factors driving the market in the near future as well as extensive research ought to be on the anvil to devise new medications.

According to FMI’s latest study, the rising incidences of MRSA all over the world are likely to create demand for safe and efficient drugs during the forecast period.

Covid-19 Pandemic: A Short-term Upholsterer

Outbreak of novel corona virus has resulted in short-term considerable increase in the number of MRSA infections. This number is expected to boost the market demand for MRSA antibiotics during the ongoing Covid-19 crisis. As per the latest data, around 2.5 million people have been infected by Covid-19 so far.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-10406

Key Takeaways of MRSA Treatment Market Study 

• In terms of drug class, glycopeptides (vancomycin) and oxazolidinones (linezolid) are collectively expected to account for over 75% of revenue share in the MRSA treatment market owing to preference of both antibiotic classes as a first-line treatment against MRSA infections and used in more than 80% of MRSA cases treatment.
• By route of administration, intravenous (IV) route of administration remains the recommended option. Drugs that can be administered through IV are likely to gain more than one-half of market share in the MRSA treatment market during the forecast period.
• By indication, skin and soft tissue infections (SSTIs) are leading the market and expected to gain more than 40% of revenue share followed by the pneumonia over the forecast period.
• Incidence of healthcare acquired MRSA is higher than community acquired MRSA, and FMI opines status-quo to remain unchanged during the assessment period
• North America is the highest revenue generating market by region due to high incidence of MRSA infections
• Asia Pacific is expected to witness high demand for MRSA testing systems due to high incidences of MRSA infection herein. For example – Journal of Family Medicine and Primary Care, in 2021, stated that occurrence of MRSA among kids aged 5 to 15 is between 16 and 52%. India alone accounts for 4-19% of these infections.

Government and Pharma Industry Focus on Working in Unison to Develop Advanced Treate  

As per University of Melbourne’s researchers, “Teixobactin” responds positively against MRSA. These results are likely to pave the way for development of antibacterial drugs to treat multi-drug resistant Gram-positive infections with thick cell wall. This will open wider doors for MRSA treatment market all over Australia and the other countries in Asia-Pacific. Teixobactin is already known for destroying Mycobacterium tuberculosis.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-10406

Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market By Category

By Drug Class :

By Indication :

• Skin and Soft Tissue Infections (SSTIs)
• Pneumonia
• Bloodstream Infections
• Surgical and Medical Infections
• Others

By Route of Administration :

• Intravenous
• Oral
• Topical
• Nasal
• Cutaneous
• Intramuscular

By Type of MSRA :

• Healthcare Acquired MRSA
• Community Acquired MRSA
• Hospital Acquired MRSA

By Distribution Channel :

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

By Region :

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-10406

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a latest study by Future Market Insights, medical face shields market will grow at over 11% CAGR through 2030. Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines

Medical face shields prove to be an effective means for first line protection against airborne diseases like Zika, SARS, Ebola, flu, and now – Covid-19. As such, increase in adoption of medical face shields, and, in turn, increase in their production is expected to drive the market in the forecast period.

The IDSA (Infectious Diseases Society of America) has, in its recommendations, included use of PPE (Personal Protective Equipment) like face shields and masks. Though masks have been widely adopted all across, their effectiveness is not that well-known.

The possibility of masks providing marginal protection against virus owing to potential moisture retention, poor filtration, and re-use of cloth masks can’t be ruled out.

On the contrary, face shields are more useful in mitigating respiratory viruses’ transmission like SARS-CoV-2, which would help in minimizing droplets and contacting transmission. However, studies have also pointed out that face shields may not effective in the absence of a masks.

According to Future Market Insights’ analysis, use of medical face shields, used in conjunction with face masks, is being explored, and it is highly likely that sales will soar dramatically in the next six months or so.

Customizable Face Shields Can Become a Reality as Pandemic Lingers On

Medical face shields available in the present scenario are meant for adults. However, child-sized face shields, that too, with interchangeable decorations are being designed now by Metaform Architects for children who have started going back to school.

These masks have been designed for children who fall in the age group of 4 to 8. There are also studs for securing personalized embellishments like googley eyes, animal ears or crowns.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-11864

Short-term Spike and Steady Growth in Long Run

According to Future Market Insights’ analysis, the staggering growth in the medical face shield market will be heavily dependent on pharmaceutical interventions to tackle COVID-19. However, even after the availability of a vaccine, it is likely that prevention better than cure approach will drive use.

“There is a growing consensus that Covid-19 may become endemic like coronaviruses. Till the time vaccines are available on a large scale, use of face shields and face masks will remain high. However, the long-term forecast on the market remains steady, as people are likely to take a preventive approach,” says the FMI analyst.

Learn about more inclusions in FMI’s report

Future Market Insights brings the coming of age research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2015 to 2030. The global medical face shield market is segmented for covering every aspect of the market and present market intelligence approach in entirety to the reader.

The study provides noteworthy insights on medical face shield market on basis of material (polycarbonate, polyethylene terephthalate glycol, acetate, and propionate) and type (anti-fog, anti-glare and others), usage (disposable and reusable), distribution channel (hospital pharmacies, retail pharmacies and online pharmacies) across seven major regions

Key Takeaways of Medical Face Shield Market

• Polycarbonate remains the material of choice for medical face shield manufacturers
• Anti-fog medical face shields likely to witness higher demand than other variants
• Disposable medical face shields will outsell reusable, as consumers look to minimize the threat of infection
• Sales through online channels likely to offset sluggishness in pharmacies and specialty stores

“The medical face shield market of 2020 and beyond will be starkly different from 2022 and before. Foray of new players, launch of innovative shields, branding & marketing, and production processes – all are set to witness a change”, says the FMI analyst.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side sand Supply Side Trends

1.3. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-11864

Key Market Segments Covered in Medical face shield Industry Research

By Material:

• Polycarbonate
• Polyethylene terephthalate glycol
• Propionate
• Acetate

By Type:

• Anti-fog
• Anti-glare
• Others

By Usage:

• Disposable
• Reusable

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-11864

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Home Health Care Market Projected to reach global market revenues of over US$ 4 Bn by the end of 2030. There are a number of reasons why the global home healthcare market is predicted to multiply in the years to come. These are: the increase in geriatric population that find it difficult to visit hospitals as well as other diagnostic centres repeatedly, the efforts undertaken by the government for promoting home healthcare, chronic illnesses, the increasing healthcare expenditure, the growing need for reasonably priced treatments, and the technological improvements in the field of pharmaceuticals as well as medical science.

However, factors like stern reimbursement policies, the safety issues of patients, as well as the low insurance coverage are acting as hurdles for the growth of home healthcare market.

The players operating in the global home healthcare market are predicted to get new income sources because of the drifting trend towards telehealth and wide unfulfilled demand from the emerging economies but only if they can meet the needs of skilled home care employees.

It is predicted that the global home healthcare market will have a significant success in the time to come. With the help of home health care, the patients receive a lot of treatments right from their homes and the home healthcare market is seen to be growing in popularity in cases where the patient does not need any major treatments, and it is also cheaper in comparison to the treatments in hospitals.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-11594

Global Home Health Care Market: Trends and Opportunities

In today’s generation where most of the services can be availed from any place, it is only the healthcare services that still require to be held in a particular and professionally controlled environment. But with the change in the attitude of consumers now require quality services right from their houses is making it necessary to decentralize health care services and provide the patients with what they prefer.

The factors that are boosting the global home healthcare market are the growth in the number of old people, the growing number of reoccurring illnesses, the favourable steps that the government has undertaken as well as the increasing need for cheap healthcare services. The primary drivers of the global home healthcare market are the growing demand for testing, monitoring, mobility care products, therapeutic products, as well as screening products, and among all these it is the need for products that are taken into use for testing for diagnosis of illnesses that are on the higher side.

Regions covered – North America (US & Canada), Europe (UK, Germany, France, Spain, Italy, Russia, BENELUX and Rest of Europe), Latin America (Brazil, Mexico, and  Rest of LA), East Asia (China, Japan and South Korea) South Asia (India, Indonesia, Malaysia, Thailand and Rest of South Asia), Oceania (Australia  and New Zealand) and MEA (GCC, South Africa, Turkey, Northern Africa and Rest of MEA)

The major players in the market include:

• Coloplast A/S
• Braun Melsungen AG
• Baxter International Inc
• Hollister Incorporated
• Becton Dickinson and Co
• ConvaTec Group Plc
• Medtronic plc..

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-11594

Market segmentation

• Product:
• Infusion Systems
  • Ambulatory Infusion Pumps
    • Disposable Ambulatory Infusion Pumps
    • Reusable Ambulatory Infusion Pumps
  • Implantable Infusion Pumps
  • Infusion Disposable Sets
  • Syringe Pumps
    • PCA Syringe Pumps
    • Standard Syringe Pumps
  • Volumetric Pumps
• Pressure Relief Devices
  • Mattress Overlays
    • Dynamic Mattress Overlays
    • Static Mattress Overlays
  • Mattresses
    • Dynamic Mattresses
    • Static Mattresses
  • Specialty Beds
• Hydrocolloids Dressings
  • Antimicrobial Hydrocolloid Dressings
  • Non Antimicrobial Hydrocolloid Dressing
• Hydrofibres Dressings
  • Antimicrobial Hydrofibre Dressings
  • Non Antimicrobial Hydrofibre Dressings
• Hydrogels Dressings
  • Antimicrobial Hydrogel Dressings
  • Non Antimicrobial Hydrogel Dressings
• Semi-Permeable Films Dressings
  • Antimicrobial Film Dressings
  • Non Antimicrobial Film Dressings
• Superabsorbents Dressings
  • Antimicrobial Superabsorbents
  • Non Antimicrobial Superabsorbents
• Wound Contact Layers
  • Antimicrobial Wound Contact Layers
  • Non Antimicrobial Wound Contact Layers
• Gauze Sponges
  • Non-Woven Gauze Sponges
  • Woven Gauze Sponges
• Gauzes
  • Non-Woven Gauzes
  • Woven Gauzes
• Sponges
  • Non-Woven Sponges
  • Woven Sponges
• Ostomy Drainage Bags
  • Colostomy Drainage Bags
    • One – Piece Colostomy Drainage Bags
    • Two – Piece Colostomy Drainage Bags
  • Ileostomy Drainage Bags
    • One – Piece Ileostomy Drainage Bags
    • Two – Piece Ileostomy Drainage Bags
  • Urostomy Drainage Bags
    • One – Piece Urostomy Drainage Bags
    • Two – Piece Urostomy Drainage Bags

Application:

• Total Parenteral Nutrition (TPN)
• IV Medication
• Pressure Ulcers
• Stoma Care

Region:

• North America Home Healthcare Market
• Latin America Home Healthcare Market
• Europe Home Healthcare Market
• East Asia Home Healthcare Market
• South Asia & Pacific Home Healthcare Market
• Middle East & Africa (MEA) Home Healthcare Market

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-11594

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs